fireflyneuro.com (AIFF) - Kewajiban jangka dawa marang modal

Firefly Neuro - logo grafis emiten AIFF

The current long-term debt-to-equity ratio for Firefly Neuroscience, Inc (AIFF) shows that the latest figure is 0.00. Firefly Neuroscience, Inc (AIFF) is implementing BNA AI analysis for the objective diagnosis of mental disorders via digital biomarkers. Redundant US cloud data centers ensure the stability of B2B services. Simultaneously, the company is deploying the BrainScope system, which automates high-precision scanning of brain functions.

Firefly Neuroscience, Inc. (AIFF): Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 30.10.2026
Produk asli Firefly Neuro

This indicator compares long-term liabilities to total equity, determining the extent to which financial stability depends on external financing. The metric measures the issuer's ability to service loans with a maturity of over one year without compromising profitability. For Firefly Neuroscience, Inc (AIFF), such borrowings could support the scaling of its cloud-based EEG analysis platform. By analyzing the ratio of long-term loans to equity, an investor assesses the balance between investment growth and debt load.

Analisis perusahaan pesaing

Rasio utang jangka dawa marang modal BIIB (Biogen Inc)|Utang jangka dawa marang modal NBIX|RGC - Kewajiban jangka dawa marang modal|Axsome Therapeutics - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal acadia-pharm.com ACAD|XENE - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Utang jangka dawa marang modal|harmonybiosciences.com - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal BHVN|Rasio tanggungan utang jangka dawa marang modal Amylyx Pharmaceuticals Inc|Utang jangka dawa marang ekuitas Trevi Pharma TRVI|Koefisien utang jangka dawa marang modal PRAX|Anavex Life Sciences - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal ceribell.com|PRTA: Utang jangka dawa marang modal|Kewajiban jangka dawa marang ekuitas ALEC (Alector)|Utang jangka dawa marang ekuitas Annexon Inc.|Utang jangka dawa marang ekuitas OMER|Rasio utang jangka dawa marang ekuitas NGNE (Neurogene Inc.)|ACIU - Kewajiban jangka dawa marang modal|Voyager Therapeutics, Inc. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal NMRA|SCLX - Utang jangka dawa marang ekuitas|TVGN (Tevogen Bio Inc.) - Rasio utang jangka dawa marang modal|ACOG: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal cogrx.com (CGTX)|Rasio utang jangka dawa marang ekuitas IKT|Utang jangka dawa marang modal Cassava Sciences Inc|Utang jangka dawa marang ekuitas Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Vistagen VTGN|Ovid Therapeutics Inc (OVID) - Kewajiban jangka dawa marang modal|ABOS - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal CervoMed, Inc. CRVO|ATHE: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Clene|PEPG (PepGen Inc) - Utang jangka dawa marang modal|jupiterneurosciences.com (JUNS) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal RLMD|ANVS - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Grace Therapeutics GRCE|KLTO: Rasio utang jangka dawa marang modal|NeuroSense Therapeutics, Ltd. - Utang jangka dawa marang modal|revivapharma.com (RVPH) - Rasio utang jangka dawa marang ekuitas|MTVA: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal NeurAxis Inc. (NRXS)|Rasio utang jangka dawa marang ekuitas HSDT|PASG: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal NEUP|Rasio tanggungan utang jangka dawa marang modal minervaneurosciences.com|Utang jangka dawa marang ekuitas Athira Pharma ATHA|ADXN: Rasio utang jangka dawa marang modal|Alzamend - Utang jangka dawa marang modal|Cyclerion Therapeutics (CYCN) - Rasio utang jangka dawa marang ekuitas|PTIX: Utang jangka dawa marang modal|Pasithea Therapeutics Corp. (KTTA) - Utang jangka dawa marang modal|CRGT (Cortigent Inc) - Utang jangka dawa marang modal|Avenue Therapeutics Inc. (ATXI) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang modal BCLI|CARA: Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal CHRO (Chromocell Therapeutics)|ELYM (Eliem Therapeutics, Inc.) - Kewajiban jangka dawa marang ekuitas|ITCI - Utang jangka dawa marang ekuitas|LBPH (Longboard Pharmaceuticals Inc) - Rasio utang jangka dawa marang modal|MRNS: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal NKGen Biotech Corp (NKGN)|Rasio utang jangka dawa marang ekuitas NRBO|Utang jangka dawa marang modal sagerx.com|Utang jangka dawa marang ekuitas Synaptogenix (SNPX)|TRVN (Trevena Inc.) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Kewajiban jangka dawa marang modal|Cerevel Therapeutics - Utang jangka dawa marang modal